Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $873.98 | 42 | 98.6% |
| Education | $12.14 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $318.98 | 15 | $0 (2024) |
| Amgen Inc. | $136.47 | 7 | $0 (2022) |
| Mallinckrodt LLC | $105.65 | 4 | $0 (2018) |
| AKEBIA THERAPEUTICS INC | $82.02 | 4 | $0 (2021) |
| Shire North American Group Inc | $46.71 | 2 | $0 (2017) |
| Relypsa, Inc. | $45.03 | 2 | $0 (2019) |
| Aurinia Pharma U.S., Inc. | $29.83 | 1 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $28.74 | 2 | $0 (2017) |
| OPKO Pharmaceuticals, LLC | $26.32 | 2 | $0 (2019) |
| Travere Therapeutics, Inc. | $23.10 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.96 | 1 | Fresenius USA Marketing, Inc. ($24.96) |
| 2023 | $114.86 | 5 | Fresenius USA Marketing, Inc. ($91.76) |
| 2022 | $193.46 | 9 | Fresenius USA Marketing, Inc. ($112.80) |
| 2021 | $160.94 | 8 | AKEBIA THERAPEUTICS INC ($82.02) |
| 2020 | $15.72 | 1 | Fresenius USA Marketing, Inc. ($15.72) |
| 2019 | $91.43 | 5 | Amgen Inc. ($37.98) |
| 2018 | $76.36 | 4 | Fresenius USA Marketing, Inc. ($34.23) |
| 2017 | $208.39 | 10 | Mallinckrodt LLC ($75.67) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/08/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $24.96 | General |
| 11/30/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $24.99 | General |
| 09/19/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $23.82 | General |
| 09/07/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $23.30 | General |
| 04/18/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.10 | General |
| 02/28/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug), KORSUVA | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/13/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug), KORSUVA | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/06/2022 | Amgen Inc. | Parsabiv (Drug), Sensipar | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Nephrology | ||||||
| 08/09/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug), KORSUVA | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/23/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/31/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/24/2022 | Vifor Pharma, Inc. | — | Education | In-kind items and services | $12.14 | General |
| 04/12/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Nephrology | ||||||
| 04/05/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/22/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/14/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Nephrology | ||||||
| 12/07/2021 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Nephrology | ||||||
| 11/02/2021 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Nephrology | ||||||
| 10/26/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Nephrology | ||||||
| 09/28/2021 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Nephrology | ||||||
| 07/20/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Nephrology | ||||||
| 05/11/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/13/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Nephrology | ||||||
| 01/14/2020 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $15.72 | General |
| 11/12/2019 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $16.30 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 651 | 1,892 | $600,587 | $249,618 |
| 2022 | 15 | 781 | 2,337 | $635,090 | $268,149 |
| 2021 | 14 | 799 | 2,419 | $629,441 | $284,334 |
| 2020 | 18 | 947 | 2,832 | $755,189 | $286,994 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 67 | 505 | $327,240 | $142,380 | 43.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 187 | 510 | $75,990 | $33,599 | 44.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 41 | 78 | $42,120 | $18,729 | 44.5% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 16 | 69 | $37,260 | $16,651 | 44.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 129 | 146 | $41,756 | $15,854 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 103 | $27,635 | $6,350 | 23.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 104 | $13,288 | $5,183 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $8,865 | $3,437 | 38.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 38 | $14,607 | $2,751 | 18.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 40 | 55 | $4,455 | $2,283 | 51.3% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2023 | 15 | 245 | $5,032 | $1,913 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $2,339 | $488.36 | 20.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 61 | 467 | $302,616 | $138,155 | 45.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 204 | 649 | $96,701 | $38,545 | 39.9% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 24 | 89 | $48,060 | $21,604 | 45.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 44 | 84 | $45,360 | $20,239 | 44.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 129 | 143 | $40,898 | $15,998 | 39.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 36 | 151 | $18,725 | $7,681 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 81 | $23,652 | $5,844 | 24.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 43 | 61 | $24,766 | $5,655 | 22.8% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 22 | 423 | $7,191 | $3,274 | 45.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 71 | 94 | $7,614 | $3,094 | 40.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $4,620 | $2,624 | 56.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 27 | $5,751 | $2,320 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 21 | $4,326 | $1,210 | 28.0% |
About Dr. David Kracker, MD
Dr. David Kracker, MD is a Nephrology healthcare provider based in Melrose Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194722934.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Kracker, MD has received a total of $886.12 in payments from pharmaceutical and medical device companies, with $24.96 received in 2024. These payments were reported across 43 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($873.98).
As a Medicare-enrolled provider, Kracker has provided services to 3,178 Medicare beneficiaries, totaling 9,480 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Melrose Park, IL
- Active Since 07/07/2005
- Last Updated 06/17/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1194722934
Products in Payments
- Velphoro (Drug) $189.89
- ACTHAR (Biological) $105.65
- Parsabiv (Drug) $98.49
- Auryxia (Drug) $82.02
- GATTEX (Drug) $46.71
- Veltassa (Drug) $45.03
- Parsabiv (Biological) $37.98
- LUPKYNIS (Drug) $29.83
- RENVELA (Drug) $28.74
- Rayaldee (Drug) $26.32
- LOKELMA (Drug) $19.12
- ZEPATIER (Drug) $12.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Melrose Park
Rizwan Moinuddin, Do, DO
Nephrology — Payments: $23,317
George Naratadam, D.o, D.O
Nephrology — Payments: $3,850
Constantine Delis, Do, DO
Nephrology — Payments: $1,627
Martin Finn, Md, MD
Nephrology — Payments: $1,555
Dr. Neetha Dhananjaya, M.d, M.D
Nephrology — Payments: $1,278
Dr. Rajani Kosuri, M.d, M.D
Nephrology — Payments: $270.02